| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018130265 |
| P356 | DOI | 10.1186/1471-2350-7-75 |
| P932 | PMC publication ID | 1617095 |
| P698 | PubMed publication ID | 17018160 |
| P5875 | ResearchGate publication ID | 6777217 |
| P50 | author | Sunita Saxena | Q30351631 |
| David Goldgar | Q91793745 | ||
| Csilla I. Szabo | Q96064531 | ||
| P2093 | author name string | Gilbert Lenoir | |
| Prakash C Sharma | |||
| Sanjeev Kotwal | |||
| Veena K Sharma | |||
| Mishi Kaushal | |||
| Anil K Aggarwal | |||
| Anurupa Chakraborty | |||
| Chintamani Chintamani | |||
| Dinesh Bhatanager | |||
| Ravindar S Mohil | |||
| P2860 | cites work | Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies | Q24531993 |
| Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan | Q24611839 | ||
| Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer | Q24796354 | ||
| Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India--a cross-sectional study | Q24814101 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
| Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response | Q28140763 | ||
| Linkage of early-onset familial breast cancer to chromosome 17q21 | Q28268902 | ||
| In search of the tumour-suppressor functions of BRCA1 and BRCA2 | Q28748477 | ||
| Identification of the breast cancer susceptibility gene BRCA2 | Q29616290 | ||
| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium | Q29619206 | ||
| Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2 | Q33910123 | ||
| Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method | Q33965225 | ||
| BRCA1 and cell signaling | Q34130576 | ||
| Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations | Q78105304 | ||
| BRCA1 and BRCA2 in Indian breast cancer patients | Q78545229 | ||
| Significant contribution of germline BRCA2 rearrangements in male breast cancer families | Q81019007 | ||
| Lessons learned from BRCA1 and BRCA2. | Q34130581 | ||
| DNA polymerase stalling, sister chromatid recombination and the BRCA genes | Q34130589 | ||
| Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing | Q34144140 | ||
| BRCA1 and BRCA2 and the genetics of breast and ovarian cancer | Q34189009 | ||
| The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals | Q34294785 | ||
| Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. | Q34334383 | ||
| BRCA1 physically associates with p53 and stimulates its transcriptional activity. | Q34467604 | ||
| Cancer risks in BRCA2 mutation carriers | Q34504452 | ||
| Cancer Incidence in BRCA1 mutation carriers | Q34527264 | ||
| Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium | Q34724404 | ||
| Evidence for a transcriptional activation function of BRCA1 C-terminal region | Q34736712 | ||
| Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? | Q35238904 | ||
| Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. | Q35436601 | ||
| Haplotype and cancer risk analysis of two common mutations, BRCA1 4184del4 and BRCA2 2157delG, in high risk northwest England breast/ovarian families | Q35444717 | ||
| Preventive intervention in breast cancer, but when? | Q35593597 | ||
| Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study | Q35881432 | ||
| The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim | Q38892074 | ||
| Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India | Q39701378 | ||
| The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds | Q41226231 | ||
| Do regular ovulatory cycles increase breast cancer risk? | Q41500964 | ||
| Common BRCA1 variants and transcriptional activation. | Q43104950 | ||
| Population genetics of BRCA1 and BRCA2. | Q43109039 | ||
| Conformation-sensitive gel electrophoresis for detecting BRCA1 mutations | Q44460352 | ||
| BRCA1 and BRCA2 mutations in women from Shanghai China | Q47197575 | ||
| BRCA1 germline mutations in Indian familial breast cancer | Q48268212 | ||
| Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer | Q48610385 | ||
| Internal repeats in the BRCA2 protein sequence | Q53173241 | ||
| Epidemiologic evidence for the increased cell proliferation model of carcinogenesis. | Q53501721 | ||
| Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families. | Q54694066 | ||
| Transcriptional activation by BRCA1 | Q59072814 | ||
| BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells | Q60568779 | ||
| Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families | Q73259292 | ||
| Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families | Q73282154 | ||
| BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central Italy | Q73692286 | ||
| Germline BRCA1 mutation analysis in Indian breast/ovarian cancer families | Q74595265 | ||
| Mutation analysis of the BRCA1 gene in Malaysian breast cancer patients | Q74630713 | ||
| Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families | Q75259366 | ||
| BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines | Q77839463 | ||
| Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer | Q77845970 | ||
| Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions | Q77931925 | ||
| P921 | main subject | India | Q668 |
| P304 | page(s) | 75 | |
| P577 | publication date | 2006-10-04 | |
| P1433 | published in | BMC Medical Genetics | Q15759918 |
| P1476 | title | Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India | |
| P478 | volume | 7 |
| Q42181679 | A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer |
| Q50909910 | Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population. |
| Q35628189 | BRCA1 and BRCA1 Genes and Inherited Breast and/or Ovarian Cancer: Benefits of Genetic Testing |
| Q35006713 | BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation |
| Q54348841 | BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients. |
| Q44367712 | BRCA1 germ-line mutations and tumor characteristics in eastern Chinese women with familial breast cancer. |
| Q36286597 | BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer |
| Q54302608 | BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity. |
| Q33575459 | Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S.--a SEER analysis |
| Q37011738 | Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations |
| Q39954978 | Cancer at ages 15-29 years: the contrasting incidence in India and England |
| Q37885224 | Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review |
| Q35695425 | Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries |
| Q40890323 | Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India |
| Q27023165 | Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer |
| Q30238500 | Epidemiology of breast cancer in Indian women |
| Q33592683 | Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis |
| Q36955087 | Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer |
| Q54279806 | Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India. |
| Q88489096 | Frequency of pathogenic germline mutations in cancer susceptibility genes in breast cancer patients |
| Q34288968 | Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer |
| Q59798483 | Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India |
| Q50138463 | Harnessing genomics to improve outcomes for women with cancer in India: key priorities for research |
| Q90717381 | How latent viruses cause breast cancer: An explanation based on the microcompetition model |
| Q36458780 | Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism |
| Q37686546 | Minor role of BRCA2 mutation (Exon2 and Exon11) in patients with early-onset breast cancer amongst Iranian Azeri-Turkish women |
| Q37316299 | Molecular genetics analysis of hereditary breast and ovarian cancer patients in India |
| Q55085561 | Mutation analysis of BRCA1/2 mutations with special reference to polymorphic SNPs in Indian breast cancer patients. |
| Q30372519 | New sequence variants in BRCA1 and BRCA2 genes detected by high-resolution melting analysis in an elderly healthy female population in Croatia. |
| Q45030564 | Novel germline mutations in BRCA2 gene among 96 hereditary breast and breast-ovarian cancer families from Kerala, South India |
| Q33355677 | Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals |
| Q36230861 | Novel sequence variants and common recurrent polymorphisms of BRCA2 in Sri Lankan breast cancer patients and a family with BRCA1 mutations |
| Q33280649 | Qualitative and quantitative dermatoglyphic traits in patients with breast cancer: a prospective clinical study |
| Q44717730 | Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history |
| Q33760464 | Role of BRCA1 and BRCA2 gene mutations in epithelial ovarian cancer in Indian population: a pilot study |
| Q35123888 | Stage at diagnosis and delay in seeking medical care among women with breast cancer, delhi, India |
| Q37510889 | The paradigm shifts in the management of breast cancer-have we finally arrived? |
Search more.